Home > Research Institute > Available Trials > Pf-08634404 vs. Pf-08634404 + other treatments in untreated metastatic Renal Cell Carcinoma
Pf-08634404 vs. Pf-08634404 + other treatments in untreated metastatic Renal Cell Carcinoma
An Interventional Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-08634404 Monotherapy And In Combination With Other Anticancer Agents In Adult Participants With Locally Advanced Or Metastatic Renal Cell Carcinoma
Disease Types: Renal
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
An Interventional Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-08634404 Monotherapy And In Combination With Other Anticancer Agents In Adult Participants With Locally Advanced Or Metastatic Renal Cell Carcinoma
For More Information:
https://clinicaltrials.gov/study/NCT07227415?term=NCT07227415&rank=1
